LD-2 disclosure · Registration
LABORATORY ACCESS & BENEFITS (LAB) COALITION
Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.
Client
- Description
- Coaltion to drive the future of laboratory and diagnostic testing policies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Health Care and Health Care Coverage
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing, including for COVID-19 testing. Issues relating to the Protecting Access to Medicare Act and laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, S. 2209. Issues relating to value-based arrangements for lab testing.
LobbyistsBRETT MEEKS
Covered position (BRETT MEEKS): Former Deputy Health Policy Director for Senate Committee on Health, Education, Labor and Pensions
